Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of AGN-151586 for moderate to severe glabellar lines in adults
CTR20240741Phase 3Completed
- Sponsor
- ——/ 艾尔建信息咨询（上海）有限公司
- Start
- Mar 2024
- Modality
- Bacterial Toxin Conjugates → Immunotoxins → Antibody Conjugates → Antibody-Based Therapeutics, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of trenibotulinumtoxinE in glabellar furrowing, sponsored by ——/ 艾尔建信息咨询（上海）有限公司. Started Mar 2024; status: completed.
02
Drugs
trenibotulinumtoxinE
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on CTR20240741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240741.